3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Observational
1
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
927
Neoplasms
609
Breast Neoplasms
605
Colorectal Neoplasms
458
Neoplasm Metastasis
394
Ovarian Neoplasms
328
Melanoma
313
Prostatic Neoplasms
311
Lung Neoplasms
294
Multiple Myeloma
292
Recurrence
278
Squamous Cell Carcinoma of Head and Neck
246
Stomach Neoplasms
229
Pancreatic Neoplasms
229
Leukemia, Myeloid, Acute
220
Triple Negative Breast Neoplasms
191
Endometrial Neoplasms
190
Carcinoma, Renal Cell
182
Lymphoma, Non-Hodgkin
179
Carcinoma, Hepatocellular
177
Small Cell Lung Carcinoma
165
Leukemia, Lymphocytic, Chronic, B-Cell
156
Advanced Solid Tumors
156
Lymphoma, Follicular
148
Urinary Bladder Neoplasms
139
Lymphoma, Large B-Cell, Diffuse
138
Lymphoma
137
Advanced Solid Tumor
137
Uterine Cervical Neoplasms
134
Head and Neck Neoplasms
134
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Multiple Sclerosis, Relapsing-Remitting
×
1 year
×
Clear all
NCT05605782
2025-06-26
ORION
Bristol-Myers Squibb
Active not recruiting
9,000 enrolled